FindTrial
Sign In

Ayurvedic formulation for the management of Asthma

CLINICAL EVALUATION OF SIMHYADI KWATH ALONG WITH SHATI CHURNA IN THE MANAGEMENT OF TAMAKA SHWAS W.R.T. BRONCHIAL ASTHMA-RANDOMIZED CONTROL STUDY

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/07/026888
Enrollment
60
Registered
2020-07-29
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J453- Mild persistent asthma

Interventions

Intervention1: Deriphyllin: 150 mg BD Intervention2: Simhyadi Kwath and Shati Churna: 20 ml QID and 2.5 gm QID, Orally for 3 months Control Intervention1: Deriphyllin: 150 mg BD, Orally for 3 months

Sponsors

Ayurvedic and Unani Tibbia College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient should be willing for the trial

Exclusion criteria

Exclusion criteria: Exclusion Criteria: Patients suffering with above disorders would be excluded : 1. Age - 60 years 2. Patients suffering from a. Pulmonary tuberculosis b. Lung Cancer, Lung fibrosis c. Emphysema, Bronchiectasis d. Cor- Pulmonale, IHD, Hypertension will be excluded. e. Status asthematicus. 3. Type ââ?¬â?? 2 Diabetes with uncontrolled blood sugar levels. 4. Patients on Corticosteroids 5. Chronicity >10yrs 6. Pregnancy 7. Patient who are not willing to participate

Design outcomes

Primary

MeasureTime frame
Improvement in subjective parametersTimepoint: follow up at 15 days interval—

Secondary

MeasureTime frame
Improvement in objective parametersTimepoint: follow up at 15 days interval—

Countries

India

Contacts

Public ContactSavan Kumar

Ayurvedic and Unani Tibbia College and Hospital

hcgupta.dr@gmail.com9354925033

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026